Nephros NEPH
NASDAQ NEPH
$4.47 -0.07 (-1.59%)
At close: Sep 11, 2026 · 4:00 PM EDT

Nephros (NEPH) Work In Process (2015 - 2022)

Nephros (NEPH) posted Work In Process of $22000.0 for Q4 2022, up 22.22% on a QoQ basis from $18000.0 in Q4 2015.

Analysis

Nephros (NEPH) Work In Process (2015 - 2022) Analysis & Trends

Nephros has reported Work In Process for 2 years, with the latest figure at $22000.0 in Q4 2022.

  • On a quarterly basis, Work In Process changed N/A year-over-year to $22000.0 in Q4 2022; TTM through Dec 2022 was $22000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $22000.0, changed N/A from the prior year.
  • Work In Process was $22000.0 for Q4 2022 at Nephros, up from $18000.0 in the prior quarter.
  • The five-year high for Work In Process was $22000.0 in Q4 2022, with the low at $22000.0 in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn
10 Nephros 48.31 Mn 43.62 Mn 4.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 22,000.00
Dec 31, 2015 18,000.00